Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Samuel D. Saibil

Phase II Clinical Trial of Adoptive Cell Therapy for Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Low-Dose Interleukin-2

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Related publications

Minimally Invasive Liver Resection to Obtain Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy in Patients With Metastatic Melanoma

World Journal of Surgical Oncology
SurgeryOncology
2012English

Efficacy of Adoptive Cell Transfer of Tumor-Infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2012English

Treatment With Tumour Infiltrating Lymphocytes and Interleukin-2 in Patients With Metastatic Melanoma: A Pilot Study

Biotherapy
1992English

Adoptive Immunotherapy With Tumor-Infiltrating Lymphocytes Against Metastatic Liver Tumors.

Acta Hepatologica Japonica
Hepatology
1989English

A Phase I Study of Nonmyeloablative Chemotherapy and Adoptive Transfer of Autologous Tumor Antigen-Specific T Lymphocytes in Patients With Metastatic Melanoma

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2002English

Phase I/Ii Trial of Melanoma Therapy With Dendritic Cells Transfected With Autologous Tumor-mRNA

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2006English

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine With Aldesleukin (Interleukin 2) and IFN- 2a Therapy in Metastatic Renal Cell Carcinoma Patients

Clinical Cancer Research
Cancer ResearchOncology
2009English

A Multi-Center Phase II Study of High Dose Interleukin-2 Sequenced With Vemurafenib in Patients With BRAF-V600 Mutation Positive Metastatic Melanoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy